SpaceX~$1TSpaceX~$1T
Insider Buying
Subscribe
All stock lists
NPCE

NeuroPace Inc (NASDAQ:NPCE)

US · Delayed Price · Currency is USD
Healthcare · Medical - Devices
$7.95-$0.19 (-2.33%)
 
Market cap
$274M
Insider Score
Health Score
Analyst consensus
Listed since
Apr 22, 2021
Market Cap$273.89M-44.6%
Revenue (ttm)$94.59M-0.3%
Net Income-$18.92M+21.1%
EPS-$0.56+26.1%
Shares Out34.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume749,375
Open$8.14
Previous Close$8.14
Day's Range$7.84 - $8.28
52-Week Range$5.46 - $19.60
Beta1.93
AnalystsBuy
Price Target$15.67(+97.11%)
Earnings DateMar 2, 2027

About NPCE

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. In addition, the company provides physician tablet which is used for prescribing and managing clinicians for programming implanted devices and managing patient care; and patient data management system, a secure online database that collects data that have been recorded by the RNS System; and nSight Platform, which provide clinicians with personalized patient reports, as well as programming suggestions. It sells its products to hospital facilities for initial RNS System implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Address
455 North Bernardo Avenue, Mountain View, CA, 94043, US
Market Cap
274 million
Employees
216
Industrial Classification
Medical - Devices

NeuroPace Inc Stock Analysis — InsiderScore

Insider Score
See top-rated InsiderScore stocks ›
92nd Percentile Overall Score
NPCE InsiderScore:94 / 99

NeuroPace Inc scored higher than 92% of companies evaluated by InsiderBuying, and ranked 2nd out of 52 stocks in the healthcare sector.

Scores are percentile-ranked against every company we scored that day, with extra weight given to the size and conviction of each purchase and the seniority of the buyer.

Dollars Committed

Insiders at NeuroPace Inc bought $302.1K of stock across 3 purchases in the last 90 days, the largest of them $103.7K.

Stake Increase

The average purchase added about 13% to the buyer's existing holding. Doubling a stake earns full marks here; topping up an already large position earns very little.

New Positions

1 of these purchases was made by someone who held no stock at all beforehand — going from nothing to a position is the strongest form of this signal.

This category carries 35% of the Insider Score.

What Are Insiders Doing?

Open-market buy / sell balanceNet Buying
Sold
$0
Bought
$302.10K

View the trades behind this meter — each links to its SEC Form 4 →

Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.

Financial Health Score
Weak
From NPCE’s reported statements · Q3 2026 (trailing 12 months)

Next catalysts

1 Day
-2.33%
5 Days
+6.14%
1 Month
-39.08%
6 Months
-51.17%
1 Year
-44.60%

$NPCE stock is featured in our Insider Score Rankings, and Insider Trades datasets.

→ All Stock Lists

Recently reported changes in NPCE holdings by institutional investors

Scanning latest 13F filings…

Latest 0 13F filings · Source: SEC EDGAR

View all institutional owners →

Insider Trading

Quarterly net insider trading by NPCE's directors and management

Net Shares Purchased by Insiders−40k−20k02025Q42026Q12026Q22026Q32026Q4

Source: SEC EDGAR (Form 4)

Corporate Lobbying

NPCE Estimated quarterly lobbying spending

Source: U.S. Senate LDA

U.S. Patents

New NPCE patent grants

Loading patent grants…

Source: USPTO Open Data Portal

Government Contracts

Estimated quarterly amount awarded to NPCE from public contracts

Source: USAspending.gov

Top ETF Holders

ETFs with the largest estimated holdings in NPCE

VTIVanguard Morningstar Total Stock Market ETF$8.81M
IWMiShares Russell 2000 ETF$5.65M
VXFVanguard Extended Market ETF$3.71M
IWOiShares Russell 2000 Growth ETF$1.97M
VTWOVanguard Russell 2000 ETF$1.91M
IWCiShares Micro-Cap ETF$655.24K

Estimated from each fund’s disclosed top holdings × AUM

Bull Case vs Bear Case

AI-generated from NPCE’s recent data — informational, not investment advice

Generating analysis…

What’s Behind the Score

Insider Activity
48% of score
93.06
Analyst Ratings
32% of score
85
News & Sentiment
20% of score
28

News check: Multiple analyst downgrades and price target cuts following Q3 earnings miss; concrete negative catalyst outweighs retention opinions.

Recent Insider Activity

Buys
3
Sells
0
Buy Value
$302.10K
Distinct Buyers
3

Insider Score Trend Over Time

+3.0 since Nov 18
0255075100Nov 18 — Insider Score 90.0Nov 19 — Insider Score 93.9Nov 20 — Insider Score 93.5Nov 21 — Insider Score 93.1Nov 18Nov 19Nov 21

Composite Insider Score (0–100) recomputed on each scoring run from live SEC Form 4 data.

Frequently Asked Questions

Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.

ETFs that hold this stock

IBRNiShares Neuroscience and Healthcare ETF0.51%
WDNAWisdomTree BioRevolution Fund0.50%
XHEState Street SPDR S&P Health Care Equipment ETF0.30%
OASCOneAscent Enhanced Small and Mid Cap ETF0.13%
SYZLazard US Systematic Small Cap Equity ETF0.12%
IWCiShares Micro-Cap ETF0.08%
FEACFidelity Covington Trust - Fidelity Enhanced U.S. All-Cap Equity ETF0.04%

Weight is the stock’s share of each fund’s holdings.